Skip to main content
Erschienen in: Herz 3/2015

01.05.2015 | Original article

Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima–media thickness

Associations in rheumatoid arthritis patients

verfasst von: A. Temiz, M.D., F. Gökmen, E. Gazi, A. Akbal, A. Barutçu, A. Bekler, B. Altun, Y.Z. Tan, F. Güneş, H. Şen

Erschienen in: Herz | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aim

The purpose of this work was to evaluate epicardial adipose tissue (EAT), carotid intima–media thickness (CIMT), and flow-mediated dilatation (FMD) of the brachial artery in rheumatoid arthritis (RA) patients using ultrasonographic methods. Interrelationships between these three parameters in RA patients were also investigated.

Methods

EAT thickness, CIMT, and FMD were measured by ultrasonography. We measured the disease activity score (DAS28), health assessment questionnaire (HAQ) score, and C-reactive protein (CRP) levels. Spearman or Pearson correlation analysis was used to evaluate the association between clinical findings, CIMT, FMD, and EAT.

Results

A total of 90 RA patients [19 men, mean age 54 years (range 21–76 years)] and 59 age- and gender-matched control subjects [17 men, mean age 54 years (range 26–80 years)] were included in the study. Patients with RA had a mean 4.34 DAS28 points (range 0–40 points) and the mean duration of the disease was 77.1 months (range 1–360 months). We found that RA patients had thicker EAT (7.7 ± 1.7 mm vs 6.2 ± 1.8 mm, p < 0.001), increased CIMT [0.9 (0.5–1.2) mm vs 0.6 (0.4–0.9) mm, p < 0.001], and decreased FMD values [5.7 % (− 23.5 to 20 %) vs. 8.5 % (− 4.7 to 22.2 %), p = 0.028] when compared to control subjects. CRP levels were significantly higher in the RA group [0.81 (range 0.1–13.5) vs 0.22 (range 0.05–12), p < 0.001]. EAT thickness was negatively correlated with FMD (r = − 0.26, p < 0.001) and positively correlated with CIMT values (r = 0.52, p < 0.001). CIMT also negatively correlated with FMD (r = − 0.29, p < 0.001).

Conclusion

EAT can be simply measured by echocardiography and correlated with FMD and CIMT. It can be used as a first-line measurement for estimating burden of atherosclerosis in RA patients.
Literatur
1.
Zurück zum Zitat Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107(9):1303–1307CrossRefPubMed Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107(9):1303–1307CrossRefPubMed
3.
Zurück zum Zitat Corrao S, Messina S, Pistone G et al (2013) Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 167(5):2031–2038CrossRefPubMed Corrao S, Messina S, Pistone G et al (2013) Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 167(5):2031–2038CrossRefPubMed
4.
Zurück zum Zitat Aviña-Zubieta JA, Choi HK, Sadatsafavi M et al (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690–1697CrossRefPubMed Aviña-Zubieta JA, Choi HK, Sadatsafavi M et al (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690–1697CrossRefPubMed
5.
Zurück zum Zitat Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862–873CrossRef Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862–873CrossRef
6.
Zurück zum Zitat Ozbalkan Z, Efe C, Cesur M et al (2010) An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis 212(2):377–382CrossRefPubMed Ozbalkan Z, Efe C, Cesur M et al (2010) An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis 212(2):377–382CrossRefPubMed
7.
Zurück zum Zitat Del Rincón I, O’Leary DH, Freeman GL, Escalante A (2007) Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 195(2):354–360CrossRef Del Rincón I, O’Leary DH, Freeman GL, Escalante A (2007) Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 195(2):354–360CrossRef
8.
Zurück zum Zitat Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467CrossRefPubMed Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467CrossRefPubMed
9.
Zurück zum Zitat Sijl AM van, Peters MJ, Knol DK et al (2011) Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 40(5):389–397CrossRefPubMed Sijl AM van, Peters MJ, Knol DK et al (2011) Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 40(5):389–397CrossRefPubMed
10.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al (2008) Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatoryrheumatic disease. Arthritis Res Ther 10(3):403–404CrossRefPubMedCentralPubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al (2008) Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatoryrheumatic disease. Arthritis Res Ther 10(3):403–404CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al (2008) Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38(2):67–70CrossRefPubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al (2008) Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38(2):67–70CrossRefPubMed
12.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38(5):366–371CrossRefPubMed Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38(5):366–371CrossRefPubMed
13.
Zurück zum Zitat Mizuno Y, Jacob RF, Mason RP (2011) Inflammation and the development of atherosclerosis. J Atheroscler Thromb 18(5):351–358CrossRefPubMed Mizuno Y, Jacob RF, Mason RP (2011) Inflammation and the development of atherosclerosis. J Atheroscler Thromb 18(5):351–358CrossRefPubMed
14.
Zurück zum Zitat Vaudo G, Marchesi S, Gerli R et al (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63(1):31–35CrossRefPubMedCentralPubMed Vaudo G, Marchesi S, Gerli R et al (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63(1):31–35CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Chatterjee Adhikari M, Guin A, Chakraborty S et al (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41(5):669–675CrossRef Chatterjee Adhikari M, Guin A, Chakraborty S et al (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41(5):669–675CrossRef
16.
Zurück zum Zitat Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196(2):756–763CrossRefPubMed Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196(2):756–763CrossRefPubMed
17.
Zurück zum Zitat Santos MJ, Vinagre F, Canas da Silva J et al (2011) Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin Exp Rheumatol 29(3):470–476PubMed Santos MJ, Vinagre F, Canas da Silva J et al (2011) Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin Exp Rheumatol 29(3):470–476PubMed
18.
Zurück zum Zitat Giles JT, Allison M, Blumenthal RS et al (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62(11):3173–3182CrossRefPubMedCentralPubMed Giles JT, Allison M, Blumenthal RS et al (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62(11):3173–3182CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Ormseth MJ, Lipson A, Alexopoulos N et al (2013) Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(9):1410–1415CrossRef Ormseth MJ, Lipson A, Alexopoulos N et al (2013) Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(9):1410–1415CrossRef
20.
Zurück zum Zitat Iacobellis G, Assael F, Ribaudo MC et al (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310CrossRefPubMed Iacobellis G, Assael F, Ribaudo MC et al (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310CrossRefPubMed
21.
Zurück zum Zitat Eroglu S, Sade LE, Yildirir A et al (2009) Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 19:211–217CrossRefPubMed Eroglu S, Sade LE, Yildirir A et al (2009) Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 19:211–217CrossRefPubMed
22.
Zurück zum Zitat Bachar GN, Dicker D, Kornowski R, Atar E (2012) Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 110(4):534–538CrossRefPubMed Bachar GN, Dicker D, Kornowski R, Atar E (2012) Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 110(4):534–538CrossRefPubMed
23.
Zurück zum Zitat Bettencourt N, Toschke AM, Leite D et al (2012) Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol 158(1):26–32CrossRefPubMed Bettencourt N, Toschke AM, Leite D et al (2012) Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol 158(1):26–32CrossRefPubMed
24.
Zurück zum Zitat Yerramasu A, Dey D, Venuraju S et al (2012) Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 220(1):223–230CrossRefPubMed Yerramasu A, Dey D, Venuraju S et al (2012) Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 220(1):223–230CrossRefPubMed
25.
Zurück zum Zitat Park HE, Choi SY, Kim MK, Oh BH (2012) Epicardial fat reflects arterial stiffness: assessment using 256-slice multidetector coronary computed tomography and cardio-ankle vascular index. J Atheroscler Thromb 19(6):570–576CrossRefPubMed Park HE, Choi SY, Kim MK, Oh BH (2012) Epicardial fat reflects arterial stiffness: assessment using 256-slice multidetector coronary computed tomography and cardio-ankle vascular index. J Atheroscler Thromb 19(6):570–576CrossRefPubMed
26.
Zurück zum Zitat Nakazato R, Dey D, Cheng VY et al (2012) Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis 221(2):422–426CrossRefPubMed Nakazato R, Dey D, Cheng VY et al (2012) Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis 221(2):422–426CrossRefPubMed
27.
Zurück zum Zitat Janik M, Hartlage G, Alexopoulos N et al (2010) Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol 17(5):841–847CrossRefPubMed Janik M, Hartlage G, Alexopoulos N et al (2010) Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol 17(5):841–847CrossRefPubMed
28.
Zurück zum Zitat Ormseth MJ, Lipson A, Alexopoulos N et al (2013) Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(9):1410–1415CrossRef Ormseth MJ, Lipson A, Alexopoulos N et al (2013) Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(9):1410–1415CrossRef
29.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRefPubMed
30.
Zurück zum Zitat Aletaha D, Ward MM, Machold KP et al (2005) Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52(9):2625–2636CrossRefPubMed Aletaha D, Ward MM, Machold KP et al (2005) Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52(9):2625–2636CrossRefPubMed
31.
Zurück zum Zitat Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367CrossRefPubMed Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367CrossRefPubMed
32.
Zurück zum Zitat Morris SJ, Wasko MC, Antohe JL et al (2011) Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 63(4):530–534CrossRef Morris SJ, Wasko MC, Antohe JL et al (2011) Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 63(4):530–534CrossRef
33.
Zurück zum Zitat Daïen CI, Duny Y, Barnetche T et al (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71(6):862–868CrossRefPubMed Daïen CI, Duny Y, Barnetche T et al (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71(6):862–868CrossRefPubMed
34.
Zurück zum Zitat Navarro-Millán I, Charles-Schoeman C, Yang S et al (2013) Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum 65(6):1430–1438CrossRefPubMedCentralPubMed Navarro-Millán I, Charles-Schoeman C, Yang S et al (2013) Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum 65(6):1430–1438CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Charles-Schoeman C, Watanabe J, Lee YY et al (2009) Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 60(10):2870–2879CrossRefPubMedCentralPubMed Charles-Schoeman C, Watanabe J, Lee YY et al (2009) Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 60(10):2870–2879CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Hahn BH, Grossman J, Ansell BJ et al (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 10(4):213CrossRefPubMedCentralPubMed Hahn BH, Grossman J, Ansell BJ et al (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 10(4):213CrossRefPubMedCentralPubMed
37.
Zurück zum Zitat Rizzo M, Spinas GA, Cesur M et al (2009) Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. Atherosclerosis 207(2):502–506CrossRefPubMed Rizzo M, Spinas GA, Cesur M et al (2009) Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. Atherosclerosis 207(2):502–506CrossRefPubMed
38.
Zurück zum Zitat Sowers JR (2003) Obesity as a cardiovascular risk factor. Am J Med 115:37–41CrossRef Sowers JR (2003) Obesity as a cardiovascular risk factor. Am J Med 115:37–41CrossRef
39.
Zurück zum Zitat Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22(11):450–457CrossRefPubMed Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22(11):450–457CrossRefPubMed
40.
Zurück zum Zitat Alexopoulos N, McLean DS, Janik M et al (2010) Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 210(1):150–154CrossRefPubMed Alexopoulos N, McLean DS, Janik M et al (2010) Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 210(1):150–154CrossRefPubMed
41.
Zurück zum Zitat Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 11:R51CrossRefPubMedCentralPubMed Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 11:R51CrossRefPubMedCentralPubMed
42.
Zurück zum Zitat Khan F, Galarraga B, Belch JJ (2010) The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 6(5):253–261CrossRefPubMed Khan F, Galarraga B, Belch JJ (2010) The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 6(5):253–261CrossRefPubMed
43.
Zurück zum Zitat Sandoo A, Kitas GD, Carroll D, Veldhuijzen van Zanten JJ (2012) The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther 14:R117CrossRefPubMedCentralPubMed Sandoo A, Kitas GD, Carroll D, Veldhuijzen van Zanten JJ (2012) The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther 14:R117CrossRefPubMedCentralPubMed
44.
Zurück zum Zitat Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ et al (2013) Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis 73:748–751CrossRefPubMed Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ et al (2013) Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis 73:748–751CrossRefPubMed
45.
Zurück zum Zitat Foster W, Carruthers D, Lip GY, Blann AD (2010) Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol 37(4):711–716CrossRefPubMed Foster W, Carruthers D, Lip GY, Blann AD (2010) Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol 37(4):711–716CrossRefPubMed
46.
Zurück zum Zitat Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7(3):R634–R643CrossRefPubMedCentralPubMed Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7(3):R634–R643CrossRefPubMedCentralPubMed
47.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A et al (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32(7):1219–1223PubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A et al (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32(7):1219–1223PubMed
48.
Zurück zum Zitat Rudominer RL, Roman MJ, Devereux RB et al (2009) Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 60(1):22–29CrossRefPubMedCentralPubMed Rudominer RL, Roman MJ, Devereux RB et al (2009) Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 60(1):22–29CrossRefPubMedCentralPubMed
49.
Zurück zum Zitat Gaasch WH, Zile MR (2011) Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol 58(17):1733–1740CrossRefPubMed Gaasch WH, Zile MR (2011) Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol 58(17):1733–1740CrossRefPubMed
Metadaten
Titel
Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima–media thickness
Associations in rheumatoid arthritis patients
verfasst von
A. Temiz, M.D.
F. Gökmen
E. Gazi
A. Akbal
A. Barutçu
A. Bekler
B. Altun
Y.Z. Tan
F. Güneş
H. Şen
Publikationsdatum
01.05.2015
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe Sonderheft 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-014-4140-z

Weitere Artikel der Sonderheft 3/2015

Herz 3/2015 Zur Ausgabe

Übersichtsarbeit

Epikardiales Fett

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.